Bone Substitutes and NIPSA in Intrabony Periodontal Defects: A Randomized Controlled Trial
Regenerative Therapy of Intrabony Periodontal Defects Using Bone Substitutes and a Minimally Invasive Nonincised Papilla Surgical Approach - A Randomized Controlled Clinical Trial
1 other identifier
interventional
30
2 countries
2
Brief Summary
This multicenter randomized controlled clinical trial aims to compare the clinical, radiographic, microbiological and molecular outcomes of two collagenated xenogeneic bone substitutes (GTO® and GenOs®) used in combination with the Non-Incised Papilla Surgical Approach (NIPSA) for the treatment of intrabony periodontal defects. The study will evaluate whether differences exist between the two biomaterials with respect to clinical attachment gain, defect resolution, wound healing and biological markers of regeneration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2026
CompletedFirst Posted
Study publicly available on registry
June 26, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
June 26, 2026
June 1, 2026
7 months
June 22, 2026
June 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical Attachment Level (CAL) gain
Change in clinical attachment level (CAL) at treated intrabony periodontal defects from baseline to 6 months following regenerative periodontal therapy using either GTO® or GenOs® in combination with the Non-Incised Papilla Surgical Approach (NIPSA).
Baseline to 6 months
Secondary Outcomes (10)
Probing Depth (PD) reduction
Baseline to 6 months
Bleeding on Probing (BOP)
Baseline to 6 months
Plaque Index (PI)
Baseline to 6 months
Radiographic bone level changes
Baseline to 6 months
Quantification of periodontal pathogens
Baseline to 6 months
- +5 more secondary outcomes
Study Arms (2)
GTO® + NIPSA
EXPERIMENTALRegenerative periodontal therapy using GTO® collagenated xenogeneic bone substitute in combination with the Non-Incised Papilla Surgical Approach (NIPSA).
GenOs® + NIPSA
ACTIVE COMPARATORRegenerative periodontal therapy using GenOs® collagenated xenogeneic bone substitute in combination with the Non-Incised Papilla Surgical Approach (NIPSA).
Interventions
Regenerative periodontal surgical treatment using the Non-Incised Papilla Surgical Approach (NIPSA) combined with GTO® collagenated xenogeneic bone substitute for the treatment of intrabony periodontal defects.
Regenerative periodontal surgical treatment using the Non-Incised Papilla Surgical Approach (NIPSA) combined with GenOs® collagenated xenogeneic bone substitute for the treatment of intrabony periodontal defects.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Diagnosis of Stage III periodontitis
- At least one intrabony periodontal defect with probing depth \> 5 mm following completion of non-surgical periodontal therapy
- Full-mouth plaque score (FMPS) \< 20%
- Full-mouth bleeding score (FMBS) \< 20%
- Ability to understand the study procedures and provide written informed consent
You may not qualify if:
- Systemic medical contraindications to periodontal surgery
- History of head and neck radiotherapy
- Poor oral hygiene or lack of motivation/compliance
- Uncontrolled diabetes mellitus
- Pregnancy or lactation
- Treatment with antiresorptive medications or other drugs affecting bone remodeling
- Heavy smoking (\>20 cigarettes/day)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Belgradelead
- Cittadella Universitariacollaborator
Study Sites (2)
Department of Periodontology, School of Dental Medicine, University of Cagliari Cittadella Universitaria di Monserrato Monserrato (CA), Italy
Cagliari, Italy, Italy
Department of Periodontology and Research Implant Center, School of Dental Medicine, University of Belgrade
Belgrade, Serbia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Iva Z Milinkovic, DDS, PhD
School of Dental Medicine, University of Belgrade, Implant Research Centre and Department of Periodontology and Oral Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 22, 2026
First Posted
June 26, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
June 26, 2026
Record last verified: 2026-06